To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Analgesic efficacy of intravenous morphine versus low-dose ketamine after long-bone fracture

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
February 2019

Analgesic efficacy of intravenous morphine versus low-dose ketamine after long-bone fracture

Vol: 8| Issue: 2| Number:7| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Efficacy and Safety of Morphine and Low Dose Ketamine for Pain Control of Patients with Long Bone Fractures: A Randomized, Double-Blind, Clinical Trial

Bull Emerg Trauma. 2018 Jan;6(1):31-36

Contributing Authors:
F Jahanian SM Hosseininejad H Amini Ahidashti F Bozorgi I Goli Khatir SH Montazar V Azarfar

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

159 patients with a long bone fracture and presenting to the emergency department were randomized to analgesia with either intravenous low-dose ketamine or intravenous morphine,. Patients were assessed over the first 240 minutes after administration for pain scores and adverse events. There were no significant differences between the two groups in Numeric Rating Scale pain scores at 30, 60, 90, 12...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue